[(8S,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-1-yl] 4-methylbenzenesulfonate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: [(8S,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-1-yl] 4-methylbenzenesulfonate
• 化学式: C₃₃H₃₈N₂O₃S
• 分子量: 542.7
• InChiKey: OTPZMVWBMKMMIF-WNDDICMISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.3
• 重原子数：
  39
• 可旋转键数：
  4
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  69.6
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF
  申请人：University of Maryland, Baltimore

  公开号：EP2968370A1

  公开（公告）日：2016-01-20
• [EN] ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF<br/>[FR] AGENTS DE DIMINUTION DU RÉCEPTEUR DES ANDROGÈNES ET LEURS UTILISATIONS
  申请人：UNIV MARYLAND BALTIMORE OFFICE OF TECHNOLOGY TRANSFER

  公开号：WO2014153215A1

  公开（公告）日：2014-09-25

  The present disclosure provides the design and synthesis of novel steroidal compounds that cause down-regulation of the androgen receptor (AR), both full length and splice variant. The compounds are potential agents for the treatment of all forms of prostate cancer and other diseases that depend on functional AR.